Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
The Korean Journal of Gastroenterology ; : 232-240, 2008.
Artículo en Coreano | WPRIM | ID: wpr-29346

RESUMEN

BACKGROUNE/AIMS: Esophageal variceal ligation (EVL) is the most preferable method for controling variceal bleeding. However, EVL is associated with complications such as hemorrhage, chest pain, dysphagia, and odynophagia due to post-EVL ulcers in the esophageal mucosa. The aim of this study was to assess the effect of proton pump inhibitor (PPI), pantoprazole on the healing of post-EVL ulcers. METHODS: Forty seven patients were randomly allocated into PPI group and control group. Patients in PPI group received 40 mg of pantoprazole intravenously for 3 days after EVL, then 40 mg of oral pantoprazole for 11 days consecutively. Control patients received intravenous and oral placebo. Endoscopic examinations were performed twice at 7+/-2 days and 14+/-2 days after EVL respectively. Clinical outcomes include the size of ulcers, symptoms reported by patients; chest pain, dysphagia, and odynophagia. RESULTS: Forty seven patients completed the 7 days protocol (PPI/control; 25/22), and twenty six patients completed the 14 days protocol (PPI/control; 16/10). Post-EVL ulcers in PPI group were significantly smaller than those in control group (7 days; 98.7 mm2/119.4 mm2, 14 days; 32.3 mm2/43.8 mm2, p0.05). Nineteen patients (PPI/control; 9/10) did not complete the 14 days protocol due to patients' refusal and adverse outcomes, such as hepatic failure and sepsis with bleeding from post-EVL ulcer occurred in two patients of control group. CONCLUSIONS: PPI treatment following EVL may be effective in healing post-EVL ulcer.


Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , 2-Piridinilmetilsulfinilbencimidazoles/administración & dosificación , Antiulcerosos/administración & dosificación , Várices Esofágicas y Gástricas/complicaciones , Esofagoscopía , Hemorragia Gastrointestinal/prevención & control , Ligadura , Inhibidores de la Bomba de Protones/administración & dosificación , Análisis de Regresión , Perfil de Impacto de Enfermedad , Úlcera/tratamiento farmacológico
2.
Journal of Korean Society of Endocrinology ; : 426-432, 2004.
Artículo en Coreano | WPRIM | ID: wpr-131906

RESUMEN

Multiple sclerosis is an autoimmune disorder, which may be associated with other rheumatologic or endocrine diseases induced by autoantibodies. Hashimoto's thyroiditis is also an organ-specific autoimmune disorder, and its association with multiple sclerosis during interferon therapy has been reported. Cases of Hashimoto's thyroiditis with multiple sclerosis are very rare. Herein is reported our experience of a 27 year-old woman who presented with general weakness, cold intolerance and progressive muscle weakness. She had been treated with levothyroxine due to subclinical hypothyroidism, which rather aggravated the symptom. In a CSF analysis, the myelin basic protein level was above 10 ng/dL and that of the IgG and the IgG index were 135 mg/dL and 7.8, respectively. In a brain MRI, demyelinating lesions in the left middle pontocerebellar junction and right subcortex were shown. She was diagnosed with multiple sclerosis, and the symptom improved after glucocorticoid and levothyroxine therapy. Herein is reported the first Korean case of Hashimoto's thyroiditis associated with multiple sclerosis


Asunto(s)
Adulto , Femenino , Humanos , Autoanticuerpos , Encéfalo , Enfermedades del Sistema Endocrino , Hipotiroidismo , Inmunoglobulina G , Interferones , Imagen por Resonancia Magnética , Esclerosis Múltiple , Debilidad Muscular , Proteína Básica de Mielina , Glándula Tiroides , Tiroiditis , Tiroxina
3.
Journal of Korean Society of Endocrinology ; : 426-432, 2004.
Artículo en Coreano | WPRIM | ID: wpr-131903

RESUMEN

Multiple sclerosis is an autoimmune disorder, which may be associated with other rheumatologic or endocrine diseases induced by autoantibodies. Hashimoto's thyroiditis is also an organ-specific autoimmune disorder, and its association with multiple sclerosis during interferon therapy has been reported. Cases of Hashimoto's thyroiditis with multiple sclerosis are very rare. Herein is reported our experience of a 27 year-old woman who presented with general weakness, cold intolerance and progressive muscle weakness. She had been treated with levothyroxine due to subclinical hypothyroidism, which rather aggravated the symptom. In a CSF analysis, the myelin basic protein level was above 10 ng/dL and that of the IgG and the IgG index were 135 mg/dL and 7.8, respectively. In a brain MRI, demyelinating lesions in the left middle pontocerebellar junction and right subcortex were shown. She was diagnosed with multiple sclerosis, and the symptom improved after glucocorticoid and levothyroxine therapy. Herein is reported the first Korean case of Hashimoto's thyroiditis associated with multiple sclerosis


Asunto(s)
Adulto , Femenino , Humanos , Autoanticuerpos , Encéfalo , Enfermedades del Sistema Endocrino , Hipotiroidismo , Inmunoglobulina G , Interferones , Imagen por Resonancia Magnética , Esclerosis Múltiple , Debilidad Muscular , Proteína Básica de Mielina , Glándula Tiroides , Tiroiditis , Tiroxina
4.
Korean Journal of Medicine ; : 190-193, 2004.
Artículo en Coreano | WPRIM | ID: wpr-90101

RESUMEN

Diffuse alveolar hemorrhage (DAH) is a relatively uncommon disorder that most often occurs in patients with systemic autoimmune or idiopathic disease. DAH may result from coagulation disorders, inhaled toxins, or infection. The principal histopathologic features of pulmonary capillaritis include capillary wall necrosis with infiltration by neutrophils, interstitial erythrocytes, and/or hemosiderin, and interalveolar septal capillary occlusion by fibrin thrombi. New inert materials such as polymerized silicones, artecoll is used as injectable aesthetic microimplants. They are still able to stimulate a clinically evident granulomatous reaction. The rate of allergic reaction is very low. We report the case of diffuse alveolar hemorrhage following administration of artecoll.


Asunto(s)
Humanos , Capilares , Colágeno , Eritrocitos , Fibrina , Hemorragia , Hemosiderina , Hipersensibilidad , Necrosis , Neutrófilos , Polímeros , Siliconas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA